AI drug tools, a new cancer pill, GLP-1 surprises and an antibody caution.

June 10, 2026

1. What leaders need to know about the breakthrough pancreatic cancer pill Full story

2. FDA accepts letter of intent for 1st AI drug development tool Full story

3. How health systems are using precision genomics to build a competitive advantage: here.

 

4. Antibody-drug therapies linked to ‘serious’ infection risks: Study Full story

5. Anthropic’s new AI model cut drug design time 10x Full story

6. VHC Health hit a 72% patient assessment completion rate for cancer risk. See how here.

 

7. The promises — and challenges — of the FDA’s real-time clinical trial model Full story

8. 7 conditions GLP-1s may treat beyond weight loss Full story

Becker’s Learning Opportunities

9. Ballad Health, Dana-Farber + others on why digital health strategies stall at the front lines: here.

10. 20% more OR minutes available. Inova’s perioperative leaders share the playbook here.

11. Cottage Health + Sinai Chicago are expanding safety-net care through specialty pharmacy and 340B reinvestment — details here.

12. Becker’s resources don’t stop here — explore more webinars and whitepapers.

 

 

Apply to attend complimentary as a guest reviewer here! Opportunity exclusive to those directly employed by a provider organization.

 
 

 

Contact Us, Feedback, or Questions – Email ldyrda@beckershealthcare.com

Manage Preferences     Unsubscribe     Forward to a friend    Contact Us     

Privacy Policy     

 

View our profile on LinkedIn Follow us on Twitter Follow us on Facebook Check out our YouTube Channel    

17 N. State, Suite 1800 | Chicago, IL 60602
Becker’s Hospital Review, A Becker’s Healthcare Publication